Clinicopathological Characteristics of Dysplastic Teratomous Neuroglia with Anti-N-methyl-d-aspartate Receptor Encephalitis.

Yangyang Xiao,Jian Li,Lingjuan Liu,Jie Xiong,Jie Xu,Qingchun Liang,Xiaoling She,Hong Tan,Yong Ma,Ding'an Mao,Liqun Liu
DOI: https://doi.org/10.1016/j.clim.2019.108271
IF: 10.19
2020-01-01
Clinical Immunology
Abstract:In this study, we investigated whether unique pathological characteristics exist in teratomas that can trigger autoimmune anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis. We compared a case of retroperitoneal teratoma associated with anti-NMDAR encephalitis and four control cases. The encephalitis-positive case showed that (i) more dysplastic neuroglia with higher Ki-67 labeling index values than the control cases, which met the diagnostic criteria of astrocytoma, (ii) the NMDAR subunit NR1 was expressed more abundantly in neuroglial tissue where many neuroglial cells co-expressed glial fibrillary acidic protein (GFAP) and NR1 and formed abnormally large cellular masses, (iii) intense NR1 expression occurs in squamous epithelium near neuroglial tissue and lymphocyte infiltration. This study showed that dysplastic neuroglial tissue resembling central nervous system tumors, which might promote autoimmunity, distinguished the case with NMDAR encephalitis from the controls. Additionally, abnormal expression of NR1 occurs in non-neural tissues and could be triggered by inflammation and participate in autoimmunity.
What problem does this paper attempt to address?